Clyde Snow’s attorneys have the expertise to represent businesses and individuals throughout the medical cannabis supply chain, including clients seeking licensure, cultivation and dispensary advice, medical cannabis pharmacy operation, leasing issues, employment issues, and investments. We also represent a full range of clients and vendors that supply secondary services to the cannabis and medical cannabis industries, such as those who provide raw materials, technology, advertising, property, finance, and other secondary products.
Our attorneys have comprehensive experience related to the cannabis industry and have robust knowledge of state and federal laws regulating the use and distribution of cannabis, medical cannabis, and cannabis related products and services, including the Controlled Substances Act, the Agriculture Improvement Act of 2018 , the Bank Secrecy Act, Anti-Money Laundering statutes, Food and Drug Administration and Utah Department of Agriculture rules and regulations, the Utah Medical Cannabis Act, the Utah Hemp and Cannabinoid Act, the Utah Cannabis Production Establishments Act, and others.
Clyde Snow attorneys stand ready to assist our cannabis-related clients in understanding and navigating state and federal regulatory frameworks; assist with applications to operate cannabis related businesses for state, city, and federal entities; assist with negotiating and documenting financing, investments, joint ventures and mergers; provide day to day regulatory advice and general business counsel; provide labor and employment advice to cannabis related entities to include workplace training, litigation, required disclosures, and workplace claims, non-competes and trade secrets, negotiation of employment and severance agreements, and drafting and maintaining cannabis-related employee handbooks. We are also well-versed in corporate governance matters, entity formation, securities offerings, bankruptcy, and litigation.